Merck

Monday November 29th, 12:00 noon

Title: Management of Nosocomial Pneumonia in Critically Ill Patients         

After attending the webinar, attendees will be able to:

  • Describe the impact of the pandemic on Antimicrobial Resistance (AMR) in Canada
  • Discuss the management of Hospital Acquired Pneumonia (HAP), Ventilator Associated Pneumonia (VAP) and ventilated Hospital Acquired Pneumonia (vHAP) in the era of COVID 19

Paladin Labs Inc.     

THU Dec. 2 12:00pm

Title: Treatment of Severe Skin Infections: Current Challenges in the Treatment of ABSSSI and New Treatment Options

Topics:

  • Current treatment of moderate to severe ABSSSI in Canada
  • Challenges in Resistance, dosing and monitoring
  • New treatment options in Canada